Solara Active Pharma Sciences Ltd share price logo

Solara Active Pharma Sciences Ltd (SOLARA)

₹487.350.67%

bell
Get free price alerts. Set up your Free investment account to get Live Prices. >
Overview
Fundamentals
Q3 '23 Results
Technicals
News and Events

Solara Active Pharma Sciences Ltd share Performance

  • ₹485
    ₹503
    ₹487.35
    downward going graph

    0.48%

    Low

    Day's Volatility:3.69%

    High

    3.21%

    downward going graph
  • ₹263.55
    ₹558.8
    ₹487.35
    downward going graph

    45.92%

    Low

    52 Weeks Volatility:60.58%

    High

    14.66%

    downward going graph
1 Month Return-16.42 %
3 Month Return+ 1.34 %
1 Year Return+ 34.98 %
Previous Close₹484.10
Open₹488.00
Volume2.43L
Upper Circuit-
Lower Circuit-
Market Cap₹2,323.44Cr

Analyst Rating

based on 2 analysts

HOLD
50.00%
Buy
0.00%
Hold
50.00%
Sell

Based on 2 analysts offering long term price targets for Solara Active Pharma Sciences Ltd. An average target of ₹350

Source: S&P Global Market Intelligence

Company Information

Solara Active Pharma Sciences Ltd is a Public Limited Company incorporated in 2017 with operations in 75 countries across the globe, primarily dealing in APIs and developing 80 commercial APIs predominantly in anthelmintic antimalarias antiinfective neuromuscular insomnia and antipsychotic hyperkalemia segments. The business is spread across North America, Europe, Japan, South Korea, Middle East and North Africa offering a basket of niche and high-value products. The Company has six manufacturing plants in Ambernath, Mangalore, Mysore, Puducherry, Vishakhapatnam and Cuddalore, with a capacity of over 2000 kilo litres and two RD Centres in Chennai and Bangalore. The facilities boast of approvals from USFDA, EDQM, KFDA, EUGMP, WHO Geneva, Cofepris, TGA Australia, and PMDA Japan. In the financial year of 2020-21, the Company achieved a Certificate of Merit from National Safety Council Maharashtra and improved EcoVadis score from 31 to 47, awarded with a bronze medal and also achieved certification for ISO 14001 and ISO 45001 in its Mangalore site. The Company also has two research and development units with 25 products in different stages of development. The Board of Directors approved the Scheme of Amalgamation of Strides Chemicals and three other Transferor Companies with the Company Transferee Company, approved the acquisition of 487000 additional share capital in Sequent Penems Private Limited, and the new Greenfield plant has commenced commercial production in 2021.

Share Price: ₹487.35 per share as on 21 May, 2024 04:01 PM
Market Capitalisation: ₹2,323.44Cr as of today
Revenue: ₹248.73Cr as on December 2023 (Q4 23)
Net Profit: ₹-275.34Cr as on December 2023 (Q4 23)
Listing date: 27 Jun, 2018
Chairperson Name: Aditya Puri
OrganisationSolara Active Pharma Sciences Ltd
HeadquartersChennai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Solara Active Pharma Sciences Ltd

  • Solara Active Pharma's Facility Clears USFDA Inspection - 21 May, 2024

    Solara Active Pharma Sciences' multipurpose API manufacturing facility in Visakhapatnam has cleared the USFDA inspection with zero form 483 observations. The company reported a decline of 38% YoY in its Q3FY24 revenue due to a fire at its Puducherry facility, resulting in an EBITDA loss of ₹161.6 crore. Despite this setback, shares of the company have risen by nearly 36% since the beginning of the year.

  • Solara Active Pharma's Facility Rated Acceptable by US FDA - 20 May, 2024

    The US FDA has completed an inspection at Solara Active Pharma Sciences Ltd's multipurpose API manufacturing facility in Visakhapatnam and rated it to be in an acceptable state of compliance with no observations. The company now has two FDA-inspected manufacturing sites for Ibuprofen drug substance.

  • Solara Active Pharma Sciences Trading at Fair Value - 11 May, 2024

    According to a 2 Stage Free Cash Flow to Equity analysis, Solara Active Pharma Sciences is trading at similar levels as its estimated fair value of ₹457 per share. Its peers are trading at a higher premium to fair value.

  • Solara Active Pharma Announces Rights Issue - 10 May, 2024

    Solara Active Pharma Sciences has announced a rights issue to raise up to Rs 450 crore at Rs 375 per share. Shareholders will receive one equity share for every three held as of the record date of May 15, with promoters committing to subscribe to their portion of the entitlement. The issue is set to open on May 28 and close on June 11.

  • Solara Active Pharma Sciences approves rights issue to raise Rs 449.95 crore - 09 May, 2024

    Solara Active Pharma Sciences has approved a rights issue to raise Rs 449.95 crore, with shares priced at Rs 375 per equity share including a premium of Rs 365 per equity share. The issue is set to open on May 28, 2024, and will close on June 11, 2024.

Fundamentals of Solara Active Pharma Sciences Ltd

Insights on Solara Active Pharma Sciences Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 121.9% return, outperforming this stock by 194.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Zydus Lifesciences Ltd has given 118.1% return, outperforming this stock by 83.1%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 30.49% of holdings in Mar 2024 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 51.14% to 50.74% in Mar 2024 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -17.16 Cr → -275.34 Cr (in ₹), with an average decrease of 1504.6% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, SOLARA stock has moved down by -3.9%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 426.42 Cr → 249.18 Cr (in ₹), with an average decrease of 41.6% per quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 16.62% to 15.80% in Mar 2024 quarter

Solara Active Pharma Sciences Ltd Valuation

Solara Active Pharma Sciences Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-1079.88x)

January 14, 2022

Today (-6.13x)

May 18, 2024

Industry (62.41x)

May 18, 2024

Highest (31.03x)

October 1, 2021

LowHigh

Mutual Fund Holdings

Funds Holdings
Aditya Birla Sun Life Flexi Cap Fund Direct Plan GrowthAditya Birla Sun Life Flexi Cap Fund Direct Plan Growth0.11%
Aditya Birla Sun Life Mid Cap Fund Direct Plan GrowthAditya Birla Sun Life Mid Cap Fund Direct Plan Growth0.13%
Aditya Birla Sun Life Manufacturing Equity Fund Direct Plan GrowthAditya Birla Sun Life Manufacturing Equity Fund Direct Plan Growth0.36%

Shareholding Pattern

InvestorsHoldings %Prev. 1 periods3M change
Promoter Holdings
30.49%
0.00
Foreign Institutions
15.8%
0.00
Mutual Funds
1.71%
0.00
Retail Investors
50.74%
0.00
Others
1.27%
0.00

Technicals of Solara Active Pharma Sciences Ltd share

News & Events of Solara Active Pharma Sciences Ltd

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Solara Active Pharma Sciences Ltd shares.

Solara Active Pharma Sciences Ltd (SOLARA) share price today is ₹487.35

Solara Active Pharma Sciences Ltd is listed on NSE

Solara Active Pharma Sciences Ltd is listed on BSE

  • Today’s highest price of Solara Active Pharma Sciences Ltd is ₹503.
  • Today’s lowest price of Solara Active Pharma Sciences Ltd is ₹485.

PE Ratio of Solara Active Pharma Sciences Ltd is -6.13

PE ratio = Solara Active Pharma Sciences Ltd Market price per share / Solara Active Pharma Sciences Ltd Earnings per share

Today’s traded volume of Solara Active Pharma Sciences Ltd(SOLARA) is 2.43L.

Today’s market capitalisation of Solara Active Pharma Sciences Ltd(SOLARA) is ₹2323.44Cr.

Solara Active Pharma Sciences Ltd(SOLARAPrice
52 Week High
₹558.8
52 Week Low
₹263.55

Solara Active Pharma Sciences Ltd(SOLARA) share price is ₹487.35. It is down -12.79% from its 52 Week High price of ₹558.8

Solara Active Pharma Sciences Ltd(SOLARA) share price is ₹487.35. It is up 84.92% from its 52 Week Low price of ₹263.55

Solara Active Pharma Sciences Ltd(SOLARAReturns
1 Day Returns
3.25%
1 Month Returns
-16.42%
3 Month Returns
1.34%
1 Year Returns
34.98%